Relievant Medsystems, Inc., a medical device start-up headquartered in Minneapolis, MN, has recently secured $50 million in funding from prominent investors such as New Enterprise Associates (NEA), Endeavour Vision, Canaan, Vensana Capital, Lightstone Ventures, Morgenthaler, and Ally Bridge Group. Founded in 2006, Relievant Medsystems is dedicated to developing innovative solutions to improve the quality of life for millions of patients suffering from chronic vertebrogenic low back pain.

Relievant's flagship product, the Intracept® System, delivers targeted energy into the spine to block the transmission of pain signals from the basivertebral nerve. This minimally invasive procedure offers spine surgeons and interventional spine physicians a new way to provide clinically proven, durable pain relief for chronic vertebrogenic low back pain.

With offices in Minneapolis, MN and Sunnyvale, CA, Relievant Medsystems is at the forefront of medical device innovation, addressing an unmet need in the treatment of chronic low back pain.

The recent funding round will further support their mission to provide effective and lasting pain relief for patients, and solidify their position in the medical device industry. To learn more about Relievant Medsystems and their innovative solutions, visit their latest funding round at https://founderlodge.com/round/Relievant-Medsystems-Inc-raises-50000000-Unknown-2023-04-21-Tyler-Binney-MTIzNTE